Washington State Medical Oncology Society (WSMOS)

Virtual Fall Conference Series November 10th, 2021

This conference series will be open to all Washington State oncology practices and institutions.
If you are interested in becoming a WSMOS member please email director@wsmosconference.org

Register now for the Washington State Medical Oncology Society (WSMOS) Virtual Fall 2021 Conference Series

Time

Wednesday November 10, 2021

5:00pm - 8:00pm

5:00pm-5:45pm Please Visit with our Corporate Sponsors over at the Exhibit Hall.
Live Chat Rooms will be open during this time. Please feel free to visit the virtual ‘exhibit hall’ at any time today through Friday November 19, 2021. We have over 30 exhibitors with lots of valuable resources and contact information for each company

Guest Speakers

5:45pm-6:00pm

Welcome & Introductions - Blair Irwin, MD, MBA WSMOS President

6:00pm-6:45pm

Accelerated Approval: A Regulatory Perspective - Julia A. Beaver, M.D. Chief of Medical Oncology, Oncology Center of Excellence, FDA Deputy Director (Acting), Office of Oncologic Diseases, Center for Drug Evaluation and Research, FDA

The talk will discuss what accelerated approval means for drug regulation, our oncology experience, approval endpoints, “dangling” accelerated approvals, challenges of the pathway, and current thinking.

6:45pm-7:30pm

COVID-19 Update - Steven Pergam, M.D., M.P.H. Associate Professor Vaccine and Infectious Disease Division, Fred Hutch Associate Professor Clinical Research Division, Fred Hutch

7:30pm-8:00pm

WSMOS Legislative Update - Kathyrn Kolan, JD

We would like to encourage all of our Hematology and Oncology colleagues in the state of Washington, including Physicians, Fellows, Emeritus, Office Managers, Administrators, Pharmacists, NP’s, PA’s, and RN’s to have your voices heard. With your support, WSMOS will continue to be the leading professional organization for oncologists in the state of Washington and a resource for the oncology community through professional education, and information dissemination.

Membership is critical to the continued advancement of WSMOS interests:

  • To identify and work to improve oncology practice issues that adversely affect patient access to cancer care.
  • To act as a patient advocate to assure that patients have access to the best available care.
  • To support and encourage clinical research against cancer. To learn more about joining the WSMOS please contact us

Wednesday November 10, 2021

Julia A. Beaver, M.D.

Chief of Medical Oncology, Oncology Center of Excellence, FDA Deputy Director (Acting), Office of Oncologic Diseases, Center for Drug Evaluation and Research, FDA

Dr. Julia A. Beaver is the Chief of Medical Oncology in the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA) and Deputy Director (acting) in the Office of Oncologic Diseases in the Center for Drug Evaluation and Research at FDA. She was previously the Director of the Division of Oncology 1.

Prior to serving as Division Director, she was Breast Cancer Team Leader and then Supervisory Associate Division Director. Through her time at FDA, she has spearheaded the authorship of multiple FDA Guidances for Industry including guidances related to expansion of eligibility criteria, male breast cancer, placebos and blinding, and metastasis-free survival.

Dr. Beaver has also published multiple regulatory research projects and co-leads the OOD/OBP Next Generation Sequencing Translational Research Laboratory. She serves on the Liquid Biopsy Blood Profiling Atlas in Cancer (Blood-PAC) committee and has particular expertise in Precision Oncology.

Dr. Beaver also is an Assistant Professor of Oncology, part-time, at Johns Hopkins University where she is a member of the Johns Hopkins Breast Cancer Group. Dr. Beaver graduated magna cum laude from Princeton University and then earned her medical degree from the University of Pennsylvania School of Medicine.

She completed a residency in Internal Medicine at Johns Hopkins University School of Medicine, followed by a fellowship in Medical Oncology at The Johns Hopkins Sidney Kimmel Cancer Center.

Steven Pergam, M.D., M.P.H.

Associate Professor Vaccine and Infectious Disease Division, Fred Hutch Associate Professor Clinical Research Division, Fred Hutch

Kathyrn Kolan, JD

Katie is part of the firm, Leonard & Kolan, Attorneys at Law – one of the premier lobbying firms in Olympia – specializing in insurance, technology, healthcare, and general business advocacy. Katie Kolan has over a decade of experience working in Olympia, developing an in-depth grasp of complicated policy issues and institutional know-how that delivers results for her clients year after year. She excels in policy analysis, political strategy and coalition building and has strong professional relationships with legislators, legislative staff, agencies, and the Governor’s office. Before joining the firm, Katie Kolan – a native of NW Washington – led the government affairs and policy team for the Washington State Medical Association for a decade. Katie holds a J.D. from Golden Gate University School of Law. Katie got the lobbying ‘bug’ after working for a state senator and in legislative roles for Columbia Legal Services, a state agency, and in other legal capacities. She has over a decade of experience in advocacy, coalition building and lobbying, and volunteer work in the community at-large. She maintains an abiding interest in healthcare and medical ethics issues, administrative law, end-of-life care, medical practice, health insurance and medical business/industry development and technology.

Speakers - May 27, 2020

Andrew McKechnie

Named one of The Hill publications “Top Lobbyists” in D.C., Andrew McKechnie brings a wealth of public policy and political experience to Peck Madigan Jones. During his time on Capitol Hill, and as a consultant, Andrew has been a key player for over a decade on many of the major legislative and regulatory efforts impacting the health care sector.

Andrew previously served as policy advisor to Senator Chuck Grassley (R-IA) while he was the Senior Republican on the Senate Finance Committee. Prior to his work with Senator Grassley and the Senate Finance Committee, he served as a Legislative Assistant to former Senator Norm Coleman (R-MN) and former Rep. Jim Ramstad (R-MN), a senior member of the Ways and Means Committee. In addition to his legislative experience on Capitol Hill, Andrew has worked on Presidential, House and Senate campaigns.

With a strong background in health care policy, Andrew is a particularly valuable resource to clients trying to navigate and respond to the highly-regulated health care industry.

Andrew lives in D.C. with his wife and two children. In his free time, he is a competitive triathlete, completing four Ironman races.

Katie Kolan, JD

Katie Kolan – a native of NW Washington – led the government affairs and policy team for the Washington State Medical Association for a decade. Katie holds a J.D. from Golden Gate University School of Law. Katie got the lobbying ‘bug’ after working for a state senator and in legislative roles for Columbia Legal Services, a state agency, and in other legal capacities.

She has over a decade of experience in advocacy, coalition building and lobbying, and volunteer work in the community at-large. She’s interest and focus in healthcare and medical ethics issues, P&C insurance law, administrative law, end-of-life care, health insurance and medical business/industry development and technology. When she’s not working, she’s likely working out and also maintains an abiding interest in sci-fi, geeking out on politics and being out in the forest for days.

Moderator for the Conference

Jennie Crews, MD

Moderator on June 25, 2020

Blair Irwin, MD

Moderator on july 2, 2020

Jennie R. Crews, MD, MMM, FACP

Medical Director, SCCA Affiliate Network, Community Sites and Research Integration Seattle Cancer Care Alliance

Moderator on May 20, 2021 and May 27, 2021